Preliminary results from Phase 1 ACESOT-1051 trial of WEE1 inhibitor, APR-1051, demonstrate the product to be well-tolerated with no unexpected ...

The "CC Chemokine Receptor Type 5 Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The CC ...

In a report released today, Jose Ruiz from Barclays maintained a Hold rating on EDP Renovaveis (0ML1 – Research Report), with a price ...

Delivery Hero said on Thursday it expects annual gross merchandise value (GMV) growth at the upper end of its forecast range, ...

Syntax Systems, a leading global technology solutions and services provider for cloud application implementation and management, ...